logo
Another bird flu strain found in U.S. dairy cattle, USDA says

Another bird flu strain found in U.S. dairy cattle, USDA says

CBC06-02-2025

U.S. dairy cattle tested positive for a strain of bird flu that previously had not been seen in cows, the U.S. Department of Agriculture said on Wednesday, ramping up concerns about the persistent spread of the virus.
The H5N1 virus has reduced milk output in cattle, pushed up egg prices by wiping out millions of hens, and infected nearly 70 people since April as it has spread across the country.
Genome sequencing of milk from Nevada identified the different strain, known as the D1.1 genotype, in dairy cows for the first time, the USDA said. Previously, all 957 bird flu infections among dairy herds reported since last March had been caused by another strain, the B3.13 genotype, according to the agency.
The D1.1 version in the Nevada cattle has been found in wild birds. It was also found in a teenager who was infected in B.C. who was treated for two months before being discharged and in a deadly case in Louisiana in January.
Reuters reported news of the detection of the second strain on Wednesday ahead of USDA's announcement.
The second strain was the predominant genotype among wild birds this past fall and winter and has also been found in poultry, the USDA said. It was identified in dairy cattle through an agency program that began testing milk for bird flu in December.
"We're seeing the H5N1 virus itself be smarter than all of us," said Beth Thompson, South Dakota's state veterinarian.
"It's modifying itself so it's not just staying in the poultry and the wild waterfowl. It's picking up a home in the mammals."
Wild birds likely transmitted the second strain to cattle in Nevada, said J.J. Goicoechea, Nevada's agriculture director. Farmers need to ramp up safety and security measures to protect their animals, he said.
"We obviously aren't doing everything we can and everything we should or the virus wouldn't be getting in," he said.
The Nevada Department of Agriculture said on January 31 that herds in two counties had been placed under quarantine due to bird flu detections.
It is important for the USDA to contain the outbreak in the state quickly, so the strain does not spread to dairy cattle elsewhere, said Gail Hansen, a veterinary and public health consultant.
Last year, bird flu spread across the country as infected cattle were shipped from Texas after the virus first leapt to cows from wild birds.
"We didn't get a hold on it before," Hansen said. "We want to avoid that same scenario from happening in Nevada."
Dairy herds that were formerly infected may be at risk again from the second strain, experts said.
"Now it looks like we have new strains of virus that may escape some of the immunity associated with the other strains of viruses that could exacerbate the epidemics among animals and wildlife," said Gregory Gray, a University of Texas Medical Branch professor studying cattle diseases.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states
Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states

Toronto Star

time5 days ago

  • Toronto Star

Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states

HARRISBURG, Pa. (AP) — Pennsylvania sued the U.S. Department of Agriculture on Wednesday, saying the agency, under President Donald Trump, had illegally cut off funding to it through a program designed to distribute more than $1 billion in aid to states to purchase food from farms for schools, child care centers, and food banks. The lawsuit in federal court, announced by Gov. Josh Shapiro, a Democrat, comes three months after the USDA advised states that it was ending the pandemic-era assistance program because it no longer reflected agency priorities. 'I don't get what the hell their priorities are if not feeding people and taking care of our farmers,' Shapiro said at a news conference at a food bank warehouse in Philadelphia. ARTICLE CONTINUES BELOW The USDA did not immediately respond to a request for comment Wednesday. The lawsuit, filed in federal court in Harrisburg, asks the court to reverse the USDA's decision to end the reimbursement program. Shapiro's administration, in the lawsuit, said the USDA's termination of the contract was illegal, saying the USDA didn't explain why it no longer reflected agency priorities and that the contract didn't expressly allow the USDA to terminate it for those reasons. Shapiro said he was confident that Pennsylvania would win the lawsuit. 'A deal is a deal,' Shapiro told the news conference. 'They made a deal with our farmers, they made a deal with Pennsylvania and they broke it.' The loss to Pennsylvania is $13 million under a three-year contract, money that the state planned to use to buy food from farms to stock food banks. States also use the money to buy food from farms for school nutrition programs and child care centers. Purchases include commodities such as cheese, eggs, meat, fruits and vegetables. The department, under then-President Joe Biden, announced a second round of funding through the program last year. ___ Follow Marc Levy on X at

Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states
Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states

Winnipeg Free Press

time5 days ago

  • Winnipeg Free Press

Pennsylvania is suing the USDA over cutting funding to a $1 billion food aid program for states

HARRISBURG, Pa. (AP) — Pennsylvania sued the U.S. Department of Agriculture on Wednesday, saying the agency, under President Donald Trump, had illegally cut off funding to it through a program designed to distribute more than $1 billion in aid to states to purchase food from farms for schools, child care centers, and food banks. The lawsuit in federal court, announced by Gov. Josh Shapiro, a Democrat, comes three months after the USDA advised states that it was ending the pandemic-era assistance program because it no longer reflected agency priorities. 'I don't get what the hell their priorities are if not feeding people and taking care of our farmers,' Shapiro said at a news conference at a food bank warehouse in Philadelphia. The USDA did not immediately respond to a request for comment Wednesday. The lawsuit, filed in federal court in Harrisburg, asks the court to reverse the USDA's decision to end the reimbursement program. Shapiro's administration, in the lawsuit, said the USDA's termination of the contract was illegal, saying the USDA didn't explain why it no longer reflected agency priorities and that the contract didn't expressly allow the USDA to terminate it for those reasons. Shapiro said he was confident that Pennsylvania would win the lawsuit. 'A deal is a deal,' Shapiro told the news conference. 'They made a deal with our farmers, they made a deal with Pennsylvania and they broke it.' The loss to Pennsylvania is $13 million under a three-year contract, money that the state planned to use to buy food from farms to stock food banks. States also use the money to buy food from farms for school nutrition programs and child care centers. Purchases include commodities such as cheese, eggs, meat, fruits and vegetables. The department, under then-President Joe Biden, announced a second round of funding through the program last year. ___ Follow Marc Levy on X at

Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows
Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

Global News

time6 days ago

  • Global News

Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug grew 50 per cent last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. That's up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children aged 12 and older. The average rate climbed further during the first three months of this year, reaching 17.3 new prescriptions per 100,000. That still represents a minute fraction of the estimated 23,000 out of every 100,000 teens in the country who are living with obesity, and is far slower than the uptake among U.S. adults. Story continues below advertisement 'It's promising that more young people are using these medications, but it's still a very small percentage of patients with severe obesity that are getting access to them,' said Dr. Cate Varney, director of obesity medicine at the University of Virginia Health system. 'When lifestyle changes alone are insufficient, we need these additional tools.' 0:57 Zepbound vs. Wegovy: Which weight-loss medication comes out on top? For its analysis, Truveta reviewed the electronic health records of 1.3 million patients ages 12 through 17. The data covers 30 U.S. health systems with more than 900 hospitals and 20,000 clinics across the country. The analysis did not include other GLP-1 drugs, including Novo's Ozempic and Eli Lilly's Zepbound, which are not approved to treat obesity in adolescents, or compounded versions of these therapies. Story continues below advertisement Should teens use weight-loss drugs? Wegovy became an option to treat adolescents in late 2022 after decades in which the conventional approaches of diet, exercise and counseling largely failed. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy About eight million American teens, or 23 per cent of people ages 12 to 19, have obesity, up from five per cent in 1980, according to U.S. government data. Young people with obesity run a much higher risk of developing chronic, costly, life-shortening conditions like Type 2 diabetes and cardiovascular and liver diseases. 1:40 Microdosing Ozempic not recommended, doctors say In January 2023, the American Academy of Pediatrics strongly recommended that doctors provide weight-loss drugs to children with obesity starting at age 12. Yet the medical community has not uniformly embraced GLP-1s for adolescents. Story continues below advertisement Some doctors are hesitant because the drugs' long-term safety for children during a critical phase of development is unknown, and the treatments may need to be used indefinitely. Overall, there are limited options for many teens and their parents because insurance plans often do not cover any treatment for obesity, including intensive behavioral counseling, visits with a dietician or the new GLP-1 medications. At Nemours Children's Hospital in Wilmington, Delaware, the Healthy Weight and Wellness Clinic treated about 2,000 adolescent patients last year. About 25 per cent were prescribed Wegovy or another GLP-1 medication, said Dr. Thao-Ly Phan, the clinic's medical director. The number of adolescents with a GLP-1 prescription nearly doubled from 2023. Does it work? On average, their patients taking a GLP-1 drug lost 15 pounds (6.8 kg) within 6 to 12 months, and nearly 30 pounds after more than a year. Story continues below advertisement For many of the other patients, the medications were not an option, either because of insurance hurdles or concern within families about potential risks. Other teens opted for lifestyle changes or older, cheaper weight-loss drugs, with some success. 'It is important for us to continue to monitor and better understand outcomes from the medications – both positive and negative – before widespread use,' Phan said. 1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer's risk for those with diabetes U.S. Health Secretary Robert F. Kennedy Jr. has criticized the idea of prescribing Ozempic or Wegovy widely to children to treat obesity. In a federal health report he released last month, GLP-1 drugs were cited as an example of the 'overmedicalization of our kids.' It noted a lack of 'long-term safety data, raising the specter of unforeseen problems that interrupt, damage, or impair metabolism and growth development.' Story continues below advertisement Novo in a statement said semaglutide, the active ingredient in Wegovy and Ozempic, 'did not appear to affect growth or pubertal development' during its clinical trials involving teens. For many adults, Novo said, obesity starts in childhood or adolescence, and 'we are confident in the proven safety and efficacy of our GLP-1 medicines.' Eli Lilly's weight-loss drug Zepbound is in late-stage clinical trials for use by adolescents. Lilly told Reuters that 'there has been no evidence to date suggesting impairment in growth or metabolism' from GLP-1 medications. Dr. Robert Siegel, a pediatrician and director of the Center for Better Health and Nutrition at Cincinnati Children's Hospital, said about 15 per cent of adolescents being treated there were prescribed Wegovy or a similar GLP-1 medication from July 2021 to July 2023. They include patients being treated for type 2 diabetes for which the GLP-1 drugs were originally developed. Siegel said he prefers to start teens on three to six months of intensive lifestyle management before even considering medication. While obesity specialists can help navigate potential risks from the drugs, many primary-care providers need more training, he said. They may not have the equipment to monitor for the loss of muscle mass – a side effect of these medicines – or lack the resources to work with families over an extended period on healthier eating and exercise. Story continues below advertisement 'These medications are likely to be needed for a very long time to maintain weight,' Siegel said, 'and we only have a relatively short-term experience with them.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store